1. Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction? 
Masaru Enomoto, Yoshiki Murakami, Norifumi Kawada 
Gastroenterology 
Volume 153, Issue 1, Pages (July 2017)
DOI: /j.gastro
Copyright © 2017 AGA Institute Terms and Conditions

2. Figure 1
The clinical course of a 74-year-old, anti-hepatitis C virus (HCV) treatment-naïve woman with chronic hepatitis C who achieved an sustained virologic response under ledipasvir plus sofosbuvir therapy. Serum HCV-RNA became negative after 8 weeks of treatment on the Roche TaqMan assay (lower limit of quantification [LLOQ], 1.2 log10 IU/mL), but remained positive during treatment and 4 weeks after the end of treatment, becoming negative 8 weeks after the end of treatment, as determined by the Abbott RealTime HCV assay (LLOQ, 1.08 log10 IU/mL). LDV, ledipasvir; SOF, sofosbuvir; TD, target detected, indicating HCV-RNA positive but < LLOQ; TND, target not detected, indicating HCV-RNA negative.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2017 AGA Institute Terms and Conditions